Literature DB >> 14514758

Parathyroid hormone protects against periodontitis-associated bone loss.

S P Barros1, M A D Silva, M J Somerman, F H Nociti.   

Abstract

Parathyroid hormone (PTH) functions as a major mediator of bone remodeling and as an essential regulator of calcium homeostasis. In addition to the well-established catabolic effects (activation of bone resorption) of PTH, it is now recognized that intermittent PTH administration has anabolic effects (promotion of bone formation). The aim of this study was to investigate whether intermittent administration of PTH in rodents would block the alveolar bone loss observed in rats when a ligature model of periodontitis is used. Morphometric analysis showed that intermittent PTH administration (40 microg/kg) was able to protect the tooth site from periodontitis-induced bone resorption. In addition, there was a significant reduction in the number of inflammatory cells at the marginal gingival area in sections obtained from animals receiving PTH compared with control animals. These findings demonstrated that intermittent PTH administration was able to protect against periodontitis-associated bone loss in a rodent model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514758     DOI: 10.1177/154405910308201006

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  20 in total

1.  Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats.

Authors:  M Wolf; S Lossdörfer; N Abuduwali; A Jäger
Journal:  Clin Oral Investig       Date:  2012-07-10       Impact factor: 3.573

Review 2.  Periodontitis and bone metabolism.

Authors:  Luigi Barbato; Edoardo Francioni; Massimiliano Bianchi; Eleonora Mascitelli; Leila Brancato Marco; Duvina Paolo Tonelli
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

3.  Intermittent administration of parathyroid hormone ameliorates periapical lesions in mice.

Authors:  Masato Otawa; Ryuichiro Tanoue; Hirofumi Kido; Yoshihiko Sawa; Junro Yamashita
Journal:  J Endod       Date:  2015-01-30       Impact factor: 4.171

4.  Doxycycline effects on serum bone biomarkers in post-menopausal women.

Authors:  L M Golub; H-M Lee; J A Stoner; R A Reinhardt; T Sorsa; A D Goren; J B Payne
Journal:  J Dent Res       Date:  2010-03-26       Impact factor: 6.116

5.  Intra-oral PTH administration promotes tooth extraction socket healing.

Authors:  S Kuroshima; B L Kovacic; K M Kozloff; L K McCauley; J Yamashita
Journal:  J Dent Res       Date:  2013-04-23       Impact factor: 6.116

6.  Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro.

Authors:  Dominik Kraus; Andreas Jäger; Nuersailike Abuduwali; James Deschner; Stefan Lossdörfer
Journal:  Clin Oral Investig       Date:  2011-03-29       Impact factor: 3.573

Review 7.  A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia.

Authors:  J F Chen; K H Yang; Z L Zhang; H C Chang; Y Chen; H Sowa; S Gürbüz
Journal:  Osteoporos Int       Date:  2014-08-20       Impact factor: 4.507

8.  Teriparatide and osseous regeneration in the oral cavity.

Authors:  Jill D Bashutski; Robert M Eber; Janet S Kinney; Erika Benavides; Samopriyo Maitra; Thomas M Braun; William V Giannobile; Laurie K McCauley
Journal:  N Engl J Med       Date:  2010-10-16       Impact factor: 91.245

9.  The effect of an inhibitor of gut serotonin (LP533401) during the induction of periodontal disease.

Authors:  G M G Lima; B J M Corazza; R M Moraes; F E de Oliveira; L D de Oliveira; G C N Franco; D S Perrien; F Elefteriou; A L Anbinder
Journal:  J Periodontal Res       Date:  2016-01-06       Impact factor: 4.419

10.  Functional characterization of the parathyroid hormone 1 receptor in human periodontal ligament cells.

Authors:  Nuersailike Abuduwali; Stefan Lossdörfer; Jochen Winter; Dominik Kraus; Stefan Guhlke; Michael Wolf; Andreas Jäger
Journal:  Clin Oral Investig       Date:  2013-04-19       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.